The 73-year-old brand's $122 million joint venture with United Trademark Group turns its single biggest licensing market into guaranteed contractual checks, and funds a credible path to cutting senior debt roughly in half by 2028. The catch: China was 48% of licensing revenue, and Playboy just sold half the upside.
Thirty-six miles from Boise sits one of the largest undeveloped copper deposits in the Western Hemisphere, and likely the largest undeveloped primary molybdenum deposit in the world. It just uplisted from the OTC and banked an $18 million raise. Now comes the decade-long, billion-dollar grind of building a mine.
Picard Medical completed a successful preclinical implant series of its next-gen Emperor artificial heart.
MEAI-based CMND-100 finished dosing all 24 Part A participants with a generally positive early safety profile. No efficacy result has been reported yet.
Bridger won a new DOI task order with its Super Scooper fleet contracted as fire season ramps.
Non-largest-customer revenue grew 52% and a ROSA unit went to the 2026 World Cup, but about 432 million shares and climbing is the story.
Most "small cap" funds start their universe at $300M. Most sell-side coverage starts at $500M. That leaves a five-year stretch of companies doing real revenue with zero professional eyes on them. Here's what the screens actually show.
Read the piece →
Going-concern language, auditor changes, share-count trajectory, insider activity. A walk-through of the quantitative and qualitative gates every name has to clear before it ends up on The Desk.
Read the methodology →